Introduction to Respiratory Infections Flashcards

(50 cards)

1
Q

most common site of infection

A

respiratory tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how many rti in children per year

A

2-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how many rti in adult per year

A

1-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

common reasons for medical consultations and time off work

A

inappropriate antibiotic prescription driving resistance
winter pressure on hospital beds
economic costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tonsilitis

A

infection of tonsils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharyngitis

A

“sore throat”
infection of pharynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

laryngitis

A

infection of larynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

tracheitis

A

infection of trachea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pleurisy

A

inflammation of pleura often caused by infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bronchiolitis

A

infection of bronchioles (small airways)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bronchitis

A

infection of bronchi (large airways)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pneumonia

A

infection of alveoli and surrounding lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

protection - colonisation

A

commensal flora and colonisation resistance
normal swallowing reflex, epiglottis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

protection - swallowing

A

neurological and anatomical factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

protection - lung anatomy

A

mucus and ciliated epithelium - mucociliary escalator
cough reflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

protection - immunity

A

innate and adaptive
soluble factors - IgA, defensins, collectin, lysozyme
alveolar macrophages
B and T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

susceptibility to RTI

A

swallowing
colonisation of upper airway
altered lung physiology
immune dysfunction
co-morbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

upper respiratory tract illness

A

viral - rhinovirus, influenza A, coronaviruses, adenoviruses, respiratory syncytial viruses, parainfluenza viruses
usually transient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

complications of upper RTI

A

sinusitis, pharyngitis, otitis media, bronchitis, rarely pneumonia
may lead to bacterial super infection
influenza A causes systemic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

rhinoviruses

A

common cold
bronchitis
sinusitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

coronaviruses

A

colds but occasionally severe resp illnesses

22
Q

adenoviruses

A

upper RTI
pharyngitis
bronchitis
occasional pneumonia

23
Q

resp syncytial viruses

A

bronchiolitis in small children
severe illness in care home residents
pneumonia in immunocompromised

24
Q

parainfluenza viruses

25
influenza A
flu
26
sars-cov-2
covid 19 severe resp illness with resp failure emerged as cause of major global pandemic in 2019 high mortality and major economic impact
27
sars-cov
severe acute resp syndrome associated coronavirus outbreak spread from china in 2002 severe resp illness with resp failure
28
middle eastern resp syndrome novel coronavirus (mers-ncv)
individual cases spread from middle east in 2012 similar to sars but low person to person spread
29
avian influenza
novel forms of influenza A occasional human cases with severe illness south-east asia associated with exposure to poultry low person to person spread
30
aetiology of pharyngitis
β-hemolytic streptococci (10-30%) viral (70-80%) - rhino/adenovirus etc glandular fever - epstein barr virus acute hiv infection
31
aetiology of sinusitis
usually viral bacterial - unilateral pain, purulent discharge, fever of >10 days/presenting acutely or with complications microorganisms streptococcus pneumoniae (40%) haemophilus influenzae (30-35%) other moraxella catarrhalis, streptococci complications - brain abcess, sinus vein thrombosis, orbital cellulitis
32
acute epiglottitis
formerly children 2-4, fever, dysphagia, drooling and stridor haemophilus influenzae type B - now rare due to Hib vaccine adults can also have - most severe from Hib, also from causes of pharyngitis, other bacterial airway infections, additional pathogens in immunocompromised - e.g. AIDS
33
bordatella pertussis
acellular vaccine may not give lifelong immunity and vaccination may have reduced boosting from natural infections adults - chronic cough, paroxyms of coughing and 50% post-ptussive vomitting complications - pneumonia, encephalopathy, subconjunctival haemorrhage
34
croup
acute laryngo-tracheobronchitis disease of children up to 6 (mostly 3mo-3yo) mainly due to parainfluenza (also RSV, IAV and other resp viruses)
35
bronchiolitis infection and inflammation
infection due to resp syncytial virus (RSV) (80%) - rarely other viruses inflammation of bronchioles and mucus production cause airway obstruction
36
bronchitis clinical features
cough may be productive or non-productive SOB and often wheeze may be fever by not systemic features of infection wheeze but no signs of focal consolidation
37
bronchitis investigations
ABG/oximetry for those with chronic lung disease - determines need for hospitalisation CXR shows no features of pneumonia - usually normal
38
bronchitis treatment
usually none especially if viral - sometimes antimicrobials manage exacerbation of COPD/asthma with steroids and increased inhalers
39
bronchiectasis
abnormal dilation of airways and suppurative infection chronic scarring of lung with excessive sputum production - bronchoohoea
40
bronchiectasis aetiology
congenital - CF, ciliary dysfunction, hypogammaglubulinemia post-infectious - TB, suppurative pneumonia measles, whooping cough other - foreign body
41
bronchiectasis symptoms
chronic cough coius sputum recurrent pneumonia weight loss
42
pneumonia aetiology
mainly streptococcus pneumoniae (40%) mycoplasma pneumoniae (~10%) chlamydophila pneumoniae (~10%) legionella pneumoniae and other spp. (<5%) haemophilus influenzae (<5%) klebsiella pneumoniae (rare, homeless and in hospital) staphylococcus aureus (low % in community but increased after influenza and in hospital) viruses (>10%)
43
people at risk of pneumonia
infants and elderly copd and other chronic lung diseases immunocompromised nursing home impaired swallow diabetes congestive heart disease alcoholics and drug users
44
community acquired pneumonia (CAP)
incidence 5-11 per 1000 20-50% hospitalised, 5-10% require ITU mortality 1% community, 10% hospital, 30% ITU hospitalisation 6-8 days significant short and long term mortality from other causes after pneumonia
45
key decisions
does the patient need antimicrobials how sick? hospital? alternative diagnosis? - heart failure, PE, cancer, TB, interstitial lung disease
46
pneumonia in immunocompromised
bacterial - all common causes but may be atypical presentation fungal - pneumocystis pneumoniae (PCP), moulds viruses - cytomegalovirus (CMV), adenovirus, RSV
47
pneumonia treatment
prompt but appropriate initiation of antimicrobials use narrowest spectrum to stop spread of resistance mild severity in community - oral antimicrobial, e.g. amoxicillin for short duration severe - IV combination - e.g. co-amoxiclav and oral clarithromycin. duration 7d mild-moderate, 7-10d severe
48
tuberculosis
chronic resp tract infection - can be extrapulmonary - usually due to reactivation of latent infection at risk - exposed, born in country of high incidence, homeless, alcoholic HIV infection
49
TB clinical features
cough haemoptysis SOB weight loss fever night sweats swollen lymph nodes/other extrapulmonary features
50
TB radiological appearances
upper lobe disease with cavities pleural disease multiple tiny nodules lymphadenopathy